238 related articles for article (PubMed ID: 22232518)
21. Shikonin reduces M2 macrophage population in ovarian cancer by repressing exosome production and the exosomal galectin 3-mediated β-catenin activation.
Wang M; Sun Y; Gu R; Tang Y; Han G; Zhao S
J Ovarian Res; 2024 May; 17(1):101. PubMed ID: 38745186
[TBL] [Abstract][Full Text] [Related]
22. PARP1-stabilised FOXQ1 promotes ovarian cancer progression by activating the LAMB3/WNT/β-catenin signalling pathway.
Wu J; Wu Y; Chen S; Guo Q; Shao Y; Liu C; Lin K; Wang S; Zhu J; Chen X; Ju X; Xia L; Wu X
Oncogene; 2024 Mar; 43(12):866-883. PubMed ID: 38297082
[TBL] [Abstract][Full Text] [Related]
23. SSRI use and clinical outcomes in epithelial ovarian cancer.
Christensen DK; Armaiz-Pena GN; Ramirez E; Matsuo K; Zimmerman B; Zand B; Shinn E; Goodheart MJ; Bender D; Thaker PH; Ahmed A; Penedo FJ; DeGeest K; Mendez L; Domann F; Sood AK; Lutgendorf SK
Oncotarget; 2016 May; 7(22):33179-91. PubMed ID: 27121207
[TBL] [Abstract][Full Text] [Related]
24. Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits β-catenin degradation.
Knoblich K; Wang HX; Sharma C; Fletcher AL; Turley SJ; Hemler ME
Cell Mol Life Sci; 2014 Apr; 71(7):1305-14. PubMed ID: 23955570
[TBL] [Abstract][Full Text] [Related]
25. Phospholipase Cδ1 suppresses cell migration and invasion of breast cancer cells by modulating KIF3A-mediated ERK1/2/β- catenin/MMP7 signalling.
Shao Q; Luo X; Yang D; Wang C; Cheng Q; Xiang T; Ren G
Oncotarget; 2017 Apr; 8(17):29056-29066. PubMed ID: 28423710
[TBL] [Abstract][Full Text] [Related]
26. Puerarin induces platinum-resistant epithelial ovarian cancer cell apoptosis by targeting SIRT1.
Duan J; Yin M; Shao Y; Zheng J; Nie S
J Int Med Res; 2021 Sep; 49(9):3000605211040762. PubMed ID: 34590923
[TBL] [Abstract][Full Text] [Related]
27. Role of nerve growth factor and its TRKA receptor in normal ovarian and epithelial ovarian cancer angiogenesis.
Vera C; Tapia V; Vega M; Romero C
J Ovarian Res; 2014 Aug; 7():82. PubMed ID: 25296882
[TBL] [Abstract][Full Text] [Related]
28. Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer.
Schneider JA; Craven TW; Kasper AC; Yun C; Haugbro M; Briggs EM; Svetlov V; Nudler E; Knaut H; Bonneau R; Garabedian MJ; Kirshenbaum K; Logan SK
Nat Commun; 2018 Oct; 9(1):4396. PubMed ID: 30352998
[TBL] [Abstract][Full Text] [Related]
29. Quantitative Expression and Co-Localization of Wnt Signalling Related Proteins in Feline Squamous Cell Carcinoma.
Giuliano A; Swift R; Arthurs C; Marote G; Abramo F; McKay J; Thomson C; Beltran M; Millar M; Priestnall S; Dobson J; Costantino-Casas F; Petrou T; McGonnell IM; Davies AJ; Weetman M; Garden OA; Masters JR; Thrasivoulou C; Ahmed A
PLoS One; 2016; 11(8):e0161103. PubMed ID: 27559731
[TBL] [Abstract][Full Text] [Related]
30. A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells.
Balch C; Naegeli K; Nam S; Ballard B; Hyslop A; Melki C; Reilly E; Hur MW; Nephew KP
Cancer Biol Ther; 2012 Jun; 13(8):681-93. PubMed ID: 22549158
[TBL] [Abstract][Full Text] [Related]
31. An LRPPRC-HAPSTR1-PSMD14 interaction regulates tumor progression in ovarian cancer.
Li D; Wang M
Aging (Albany NY); 2024 Apr; 16(8):6773-6795. PubMed ID: 38643468
[TBL] [Abstract][Full Text] [Related]
32. Secreted frizzled-related protein 4: an angiogenesis inhibitor.
Muley A; Majumder S; Kolluru GK; Parkinson S; Viola H; Hool L; Arfuso F; Ganss R; Dharmarajan A; Chatterjee S
Am J Pathol; 2010 Mar; 176(3):1505-16. PubMed ID: 20056841
[TBL] [Abstract][Full Text] [Related]
33. Over-expression of ASIC1a promotes proliferation via activation of the β-catenin/LEF-TCF axis and is associated with disease outcome in liver cancer.
Jin C; Yuan FL; Gu YL; Li X; Liu MF; Shen XM; Liu B; Zhu MQ
Oncotarget; 2017 Apr; 8(16):25977-25988. PubMed ID: 27462920
[TBL] [Abstract][Full Text] [Related]
34. Dynamics and evolution of β-catenin-dependent Wnt signaling revealed through massively parallel clonogenic screening.
Shah PK; Walker MP; Sims CE; Major MB; Allbritton NL
Integr Biol (Camb); 2014 Jul; 6(7):673-84. PubMed ID: 24871928
[TBL] [Abstract][Full Text] [Related]
35. Dysregulation of Wnt/β-catenin signaling contributes to intestinal inflammation through regulation of group 3 innate lymphoid cells.
Hao J; Liu C; Gu Z; Yang X; Lan X; Guo X
Nat Commun; 2024 Apr; 15(1):2820. PubMed ID: 38561332
[TBL] [Abstract][Full Text] [Related]
36. Divergent Malignant Melanocytic Differentiation in Ovarian Endometrioid Adenocarcinoma With Aberrant β-Catenin Expression: A Case Expanding the Histologic Spectrum of β-Catenin Activated Gynecologic Neoplasia.
Xu J; Weisman PS
Int J Gynecol Pathol; 2024 May; 43(3):302-307. PubMed ID: 37922945
[TBL] [Abstract][Full Text] [Related]
37. Sphingolipid metabolites modulate dielectric characteristics of cells in a mouse ovarian cancer progression model.
Salmanzadeh A; Elvington ES; Roberts PC; Schmelz EM; Davalos RV
Integr Biol (Camb); 2013 Jun; 5(6):843-52. PubMed ID: 23609351
[TBL] [Abstract][Full Text] [Related]
38. HMGB1-mediated transcriptional activation of circadian gene TIMELESS contributes to endometrial cancer progression through Wnt-β-catenin pathway.
Wang Z; He S; Xin L; Zhou Y; Zhao L; Wang F
Cell Signal; 2024 Apr; 116():111045. PubMed ID: 38211843
[TBL] [Abstract][Full Text] [Related]
39. Engineered Wnt7a ligands rescue blood-brain barrier and cognitive deficits in a COVID-19 mouse model.
Trevino TN; Fogel AB; Otkiran G; Niladhuri SB; Sanborn MA; Class J; Almousawi AA; Vanhollebeke B; Tai LM; Rehman J; Richner JM; Lutz SE
Brain; 2024 May; 147(5):1636-1643. PubMed ID: 38306655
[TBL] [Abstract][Full Text] [Related]
40. Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells.
Garrido MP; Salvatierra R; Valenzuela-Valderrama M; Vallejos C; Bruneau N; Hernández A; Vega M; Selman A; Quest AFG; Romero C
Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33081077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
